SERAXIS Inc., a privately held regenerative medicine company today announced the successful production of stem cell derived pancreatic cells capable of regulating blood glucose in rodent models of insulin dependent diabetes.
{iframe}https://www.prnewswire.com/news-releases/seraxis-inc-announces-novel-method-and-cell-line-that-generate-highly-pure-populations-of-insulin-producing-cells-capable-of-reversing-diabetes-in-rodents-300707580.html{/iframe}